FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Adamo, M. C.
Right arrow Articles by Pessia, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Adamo, M. C.
Right arrow Articles by Pessia, M.
(The FASEB Journal. 1999;13:1335-1345.)
© 1999 FASEB

Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K+ channel function

Maria Cristina D'Adamo, Paola Imbrici, Fabio Sponcichetti and Mauro Pessia1

Istituto di Ricerche Farmacologiche [Mario Negri], Consorzio Mario Negri Sud, Department of Pharmacology and Molecular Pathology, Chieti, Italy

1Correspondence: Istituto di Ricerche Farmacologiche [Mario Negri], CMNS, 66030 Santa Maria Imbaro, Chieti, Italy. E-mail: Pessia{at}cmns.mnegri.it


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Episodic ataxia type-1 syndrome (EA-1) is an autosomal dominant neurological disorder that manifests itself during infancy and results from point mutations in the voltage-gated potassium channel gene hKv1.1. The hallmark of the disease is continuous myokymia and episodic attacks of spastic contractions of the skeletal muscles, which cause permanent disability. Coexpression of hKv1.1 and hKv1.2 subunits produces heteromeric potassium channels with biophysical and pharmacological properties intermediate between the respective homomers. By using tandemly linked subunits, we demonstrate that hKv1.1 subunits bearing the EA-1 mutations V408A and E325D combine with hKv1.2 to produce channels with altered kinetics of activation, deactivation, C-type inactivation, and voltage dependence. Moreover, hKv1.1V408A single-channel analysis reveals a ~threefold reduction of the mean open duration of the channel compared with the wild-type, and this mutation alters the open-state stability of both homomeric and heteromeric channels. The results demonstrate that human Kv1.2 and Kv1.1 subunits coassemble to form a novel channel with distinct gating properties that are altered profoundly by EA-1 mutations, thus uncovering novel physiopathogenetic mechanisms of episodic ataxia type-1 myokymia syndrome.—D'Adamo, M. C., Imbrici, P., Sponcichetti, F., Pessia, M. Mutations in the KCNA1 gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K+ channel function.


Key Words: potassium channel gating • hKv1.1 • hKv1.2· myokymia • cerebellum


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
EPISODIC ATAXIA TYPE-1 (EA-1)2 is a human neurological syndrome that occurs during infancy or early childhood and persists throughout the entire life of affected patients. The hallmark of the disease is continuous myokymia and episodic attacks of spastic contractions of the skeletal muscles, which often result in loss of balance. In severely affected individuals, generalized attacks of ataxic gait may last for hours and may occur several times a day (1 2 3) . Interictal nystagmus and migraine are not usually observed in EA-1 patients. In contrast, they are distinctive symptoms of individuals affected by episodic ataxia type-2, which has been associated with mutations in the P/Q-type calcium channel {alpha}1 subunit gene CACNL1A4 (4) .

Several heterozygous point mutations have been found in the coding sequence of the voltage-gated potassium channel gene KCNA1 (hKv 1.1) of various EA-1-affected families. These mutations occur at highly conserved positions in the transmembrane domain 1 and 2 (S1 and S2), in the loops linking S2 to S3 and S4 to S5, and in S6 (5 6 7 8 9 10 11) . The characterization of human Kv1.1 channels bearing a number of EA-1 mutations in Xenopus oocytes has revealed that these amino acid substitutions reduce their delayed-rectifier function by altering several potassium channel biophysical and biochemical properties (12 13 14 15) .

Potassium channel diversity is greatly enhanced by the ability of different types of {alpha} subunits to heteropolymerize and form channels with properties different from the parental homomeric channels (16 17 18 19) .

Biochemical and biophysical studies have shown that mammalian Kv1.1 and Kv1.2 subunits are colocalized in several subcellular brain regions important for the control of movement and heteropolymerize to form channels (16 , 18 , 20 21 22 23 24 25) . Particularly intriguing is the presence of both subunits in the Ranvier's nodes of myelinated axons and at the level of the cerebellar Pinceau, a structure composed of several basket cell terminals that embrace the Purkinje cell axon hillock and proximal axon segment (22 , 23 , 25) . Purkinje cell axons represent the only output system of the cerebellar cortex and the Pinceau appear to passively hyperpolarize these axons by generating fast inhibitory electrical fields (26) . Moreover, patch-clamp recordings from Purkinje cells have revealed that {alpha}-DTX selectively blocks the Kv1.1 and Kv1.2 potassium channels from basket cell presynaptic terminals and increases both the amplitude and frequency of spontaneous IPSCs mediated by GABAA receptor activation (27) . These findings suggest that Kv1.1 and Kv1.2 heteromeric channels may contribute to the excitability and the rapid repolarization phase of action potentials in myelinated axons and basket cell terminals, where they modulate the release of the neurotransmitter {gamma}-aminobutyric acid (GABA) onto Purkinje cells.

To ascertain whether heteropolymerization occurs between the human potassium channel members hKv1.2 and hKv1.1 and whether EA-1 mutations affect heteromeric channel function, we determined the biophysical properties of channels obtained from the coexpression of both mRNAs in Xenopus oocytes, as well as of channels comprised of the concatenated dimeric subunits, hKv1.2 linked to mutant or wild-type hKv1.1. The results demonstrate that human Kv1.2 and Kv1.1 subunits coassemble to form a distinct channel and that EA-1 mutations profoundly impair several of the novel heteromeric K+ channel properties, thus uncovering new physiopathogenetic mechanisms of episodic ataxia type-1 myokymia syndrome.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Molecular biology
To concatenate as dimers the hKv1.2 wild-type with the episodic ataxia hKv1.1 subunits, the stop codon of the first subunit was removed and a linker encoding 10 glutamine residues was inserted between the last codon of the 5' subunit coding sequence and the initiator codon of the following subunit. This was achieved by using a sequential polymerase chain reaction protocol modified from Horton, as described previously (12 , 28) . The nucleotide sequences of all linked subunits were determined throughout the joined segments by automated sequencing. Oligonucleotides were obtained from EUROBIO, Milan, Italy.

Electrophysiology
Xenopus oocytes dissection and injections were performed as described (12) . The amount of mRNA injected was determined by spectrophotometer and ethidium bromide stain.

Two-electrode voltage-clamp recording
The oocyte currents were recorded 1–8 days later with a GeneClamp 500 amplifier (Axon Instruments, Foster City, Calif.) interfaced to a Power Macintosh 7200/90 computer with an ITC-16 computer interface (Instrutech Corp., Great Neck, N.Y.). The recording solution contained (mM): NaCl 96, KCl 2, MgCl2 1, CaCl2 1.8, HEPES 5, pH=7.4. Data acquisition and analysis were performed using Pulse+PulseFit (HEKA elektronik GmbH, Germany), KaleidaGraph (Synergy Software), and IGOR (Wavemetrics) software. Leak and capacitative currents were subtracted by using a P/4 protocol.

Patch-clamp recording
Inside-out patch recordings were performed with an Axopatch 200B amplifier (Axon Instruments). The pipette solution contained (mM): NaCl 120, KCl 2, CaCl2 0.1, HEPES 5, pH=7.4; the cytoplasmic solution contained (mM): KCl 120, EGTA 1, HEPES 5, pH=7.4. Pipettes were pulled from 7052 glass type (Garner Glass Co., Claremont, Calif.) and had a resistance of 5–10 M{Omega}. The recordings were leak subtracted by using averaged sweeps with no opening fitted with exponential functions, filtered at 0.5–2 kHz with a four pole low-pass Bessel filter and acquired at 5–10 kHz with a Pulse+PulseFit program (HEKA elektronik GmbH). Channel activity was analyzed (as described by Hoshi et al., 29 ) with a TAC-TACfit program (Bruxton Co., Seattle, Wash.) by visual inspection and measurement of channel openings (event-by-event mode). Duration histograms were corrected for the corner frequency of the low-pass filter used.


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
hKv1.2 and hKv1.1 heteropolymerization
To determine whether human Kv1.2 and Kv1.1 form heteromeric channels, equal amounts of mRNA for each subunit were injected together or separately into Xenopus oocytes. The delayed-rectifier currents resulting from oocytes coinjected with both hKv1.2 and hKv1.1 mRNAs showed a half-maximal activation voltage V1/2 and a slope factor k of -16.3 ± 2.1 mV and 7.9 ± 2.7 mV (n=13), respectively. These voltage-dependent parameters were intermediate between those obtained from oocytes expressing hKv1.1 or hKv1.2 homomers (Table 1 ), suggesting that these subunits may assemble to form heteromeric channels with different relative stoichiometries.


View this table:
[in this window]
[in a new window]
 
Table 1. Biophysical parameters of homomeric and heteromeric channelsa

To control the stoichiometry of the coexpressed subunits to determine the biophysical parameters of a presumed homogeneous population of heterotetrameric channels composed of two subunits of each type, we concatenated the hKv1.2 with the hKv1.1 subunit (hKv1.2–1.1wt) with a flexible glutamine linker. The expression of the hKv1.2–1.1wt concatemer in Xenopus oocytes gave rise to functional delayed rectifier currents displaying voltage-dependent parameters intermediate between the respective homomers, confirming the results obtained form the coexpression experiments (Fig. 1 A, B; Table 1 ).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1. Human Kv1.1 and Kv1.2 subunit heteropolymerization. A) Representative current traces recorded in Xenopus oocytes expressing hKv1.1, hKv1.2, and hKv1.2–1.1wt concatenated subunits and evoked by a depolarizing pulse at +20 mV (approximately the peak of an action potential), from holding potential of -80 mV; tail currents were recorded at -50 mV. B) Current-voltage relationships obtained by plotting the peak tail currents recorded at -50 mV as a function of the pre-pulse potential for hKv1.1 (triangles), hKv1.2 (circles) and hKv1.2–1.1wt (squares) channels. The solid lines represent the fit with the Boltzmann function: I=1/1+exp{-(V-V1/2)/k} from which the V1/2 and slope factor k were computed. C) hKv1.1 (triangles) hKv1.2 (circles), and hKv1.2–1.1wt (squares) activating and deactivating current traces were fitted with double and single exponential functions, respectively, and the time constants were plotted as a function of membrane potential. The data points are the mean of 5–7 cells (standard deviations have been omitted for clarity) and were fitted with the equation: {tau} = {tau}V1/2 exp{(V-V1/2)/k}, where {tau}V1/2 is the time constant at the V1/2 of the channels and k is the slope factor for the voltage dependence of the time constants. D) Blockade of hKv1.1 (triangles), hKv1.2 (circles), hKv1.2–1.1wt (squares), and hKv1.2–1.1Y379V (diamonds) currents by tetraethylammonium ions. The data points are the mean ± SD of 6–8 cells and represent the current inhibition recorded at +40 mV, normalized by the control current and plotted as a function of TEA concentration. Solid lines are the fit with the equation I/Io = Ki/(Ki+[TEA]), from which the Ki values were computed.

To compare the kinetics of activation and deactivation for hKv1.1, hKv1.2 and hKv1.2–1.1wt channels, activating and deactivating current traces were fitted with double and single exponential functions, respectively (12 , 15) . The plot of time constants as a function of membrane potential (Fig. 1C ) revealed that hKv1.2–1.1wt channels had kinetics of activation distinct and intermediate between the respective homomeric channels.

A similar sensitivity to tetraethyl-ammonium (TEA) ion blockade of Drosophila Shaker channels was shown by hKv1.1 homotetrameric channels (Ki= 0.368 ± 0.02 mM; Fig. 1D ; 13, 15). The tyrosine residue 379, located in the outer mouth of the hKv1.1 pore endows the channel with high sensitivity to TEA ions (Fig. 2 A; 13). In contrast, hKv1.2 channels possess a valine residue at this position and showed a much lower affinity to TEA (Ki= 232 ± 7.5 mM; Fig. 1D ). On the other hand, heteromeric hKv1.2–1.1wt channels displayed a TEA sensitivity intermediate between the homomeric hKv1.2 and hKv1.1 channels (Ki= 85.6 ± 14.8 mM; Fig. 1D ). To investigate the role of the tyrosine residue endowing concatenated heteromeric channels with intermediate sensitivity to TEA, we constructed a dimer in which a hKv1.2 subunit was linked to a hKv1.1 subunit with the Tyr 379 residue mutated into a valine (hKv1.2–1.1Y379V). The TEA concentration-response curve for hKv1.2–1.1Y379V channels was shifted toward the hKv1.2 values (Ki= 200 ± 15 mM; Fig. 1D ). Taken together, these results demonstrate that human heteromeric K+ channels composed of hKv1.2 and hKv1.1 subunits may be formed. Moreover, the data suggest that the expression of hKv1.2–1.1wt linked subunits in Xenopus oocytes gives rise to heterotetrameric channels containing two subunits of each type, which are expected to be mostly located tandemly (30) .



View larger version (21K):
[in this window]
[in a new window]
 
Figure 2. EA-1 mutations alter the kinetics of activation, deactivation, and voltage dependence of heteromeric channels. A) hKv1.1 and hKv1.2 membrane topology and amino acid sequence alignment of the indicated regions. Positions of the E325D, Y379V, and V408A mutations are marked by arrows. B) Normalized and superimposed representative current traces recorded from oocytes expressing the indicated channels. C) Current-voltage relationships for hKv1.2–1.1wt (open squares), hKv1.2–1.1V408A (filled triangles), and hKv1.2–1.1E325D (open diamonds) channels. D) Time constants of activation and deactivation for hKv1.2–1.1E325D (filled triangles) hKv1.2–1.1V408A (open diamonds) channels; for comparison, hKv1.2–1.1wt values are shown as solid lines (data points are the mean of 5–7 cells and the standard deviations have been omitted for clarity). The traces and results depicted are recorded and computed as described in Fig. 1 .

E325D and V408A mutations alter the voltage dependence, kinetics, and inactivation of heteropolymeric channels
To determine whether EA-1 mutations affect the functions of heteromeric channels, hKv1.2 subunits were linked as dimers with hKv1.1E325D and hKv1.1V408A mutant subunits (hKv1.2–1.1E325D; hKv1.2–1.1V408A; Fig. 2A ) because they markedly alter several gating properties of the channel (12 , 13) . The expression of hKv1.2–1.1V408A dimeric construct in Xenopus oocytes produced functional channels with voltage-dependent parameters not significantly different from 1.2–1.1wt channels (Fig. 2B, C ; Table 1 ). In contrast, the half-maximal activation voltage V1/2 for hKv1.2–1.1E325D channels was shifted 21.8 mV to more positive potentials and the slope factor k was increased 1.5-fold compared with 1.2–1.1wt channels (Fig. 2C ; Table 1 ). These results demonstrate that the voltage dependence of heteromeric channels is altered by the assembling of hKv1.1E325D subunits.

To determine whether E325D and V408A mutations affect the kinetics of activation and deactivation of heteromeric channels, hKv1.2–1.1E325D and hKv1.2–1.1V408A current traces were fitted with exponential functions and the time constants were plotted as a function of test potential (Fig. 2D ). Such analysis revealed that hKv1.2–1.1E325D and hKv1.2–1.1V408A channels activate at V1/2 with ~twofold and ~fivefold faster kinetics than hKv1.2–1.1wt channels, respectively (Fig. 2D ; Table 1 ). Similarly, the time constants of deactivation at V1/2 for hKv1.2–1.1E325D and hKv1.2–1.1V408A channels were ~eightfold and ~sixfold faster than hKv1.2–1.1wt channels. The data demonstrate that both E325D and V408A mutations alter the kinetics of activation and deactivation of heteromeric channels and may destabilize their open state.

In previous studies it was reported that E325D and V408A mutations increased the rate of C-type inactivation (12 , 13 , 15) . To assess whether such mutations affect also the inactivation properties of heteromeric channels, the membrane potential of oocytes expressing hKv1.2–1.1E325D and hKv1.2–1.1V408A channels was held at -80 mV and current traces were evoked by depolarizations at +20 mV for 3.5 min. The superimposed current traces presented in Fig. 3 A clearly show that hKv1.2–1.1E325D and hKv1.2–1.1V408A channels undergo a faster C-type inactivation process than hKv1.2–1.1wild-type channels. The decaying phase of the currents was best fitted with double exponential functions and the fast time constants for hKv1.2–1.1E325D and hKv1.2–1.1V408A channels were ~1.6-fold and ~3.4-fold faster than hKv1.2–1.1wild-type channels, respectively (Table 2 ).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 3. EA-1 mutations affect the C-type inactivation of heteromeric channels. A) Normalized current traces showing the C-type inactivation time course for the indicated channels; the dashed line represents the zero current level. B) Recovery from C-type inactivation for hKv1.2–1.1wt (open squares), hKv1.2–1.1V408A (filled triangles), and hKv1.2–1.1E325D (open diamonds) determined at +20 mV with two-pulse experiments. The data points are the mean ± SD of 6 cells.


View this table:
[in this window]
[in a new window]
 
Table 2. C-type inactivation kineticsa

The recovery from C-type inactivation of the heteromeric mutant channels was also faster (Fig. 3B ). In fact, the slow time constants for hKv1.2–1.1E325D and hKv1.2–1.1V408A channels were ~3.7-fold and ~2.7-fold faster than hKv1.2–1.1wild-type channels, respectively (Table 2) . These results demonstrate that heteromeric channels comprising either hKv1.1E325D or hKv1.1V408A subunits undergo a faster C-type inactivation process and possess a less stable inactivated state.

V408A mutation alters the single-channel kinetics of homomeric and heteromeric channels
Valine 408 is a highly conserved residue located in the carboxyl-terminal portion of S6 that lies in the ion-conducting pore (Fig. 2A ; 31, 32). Moreover, this region appears to comprise part of an intracellular gate that hypothetically opens and closes Shaker K+ channels (33) . To investigate the effects of V408A mutations on homomeric and heteromeric single-channel kinetics, inside-out patch-clamp recordings were performed with Xenopus oocytes expressing hKv1.2–1.1wt, hKv1.2–1.1V408A, and hKv1.1V408A channels (Fig. 4 ). Heteromeric hKv1.2–1.1wt channels showed a single-channel slope conductance of 9.6 ± 1.2 pS (n=3) that was not significantly different from the hKv1.2–1.1V408A and hKv1.1V408A conductances of 9.7 ± 0.6 pS (n=3) and 10.0 ± 1.0 pS (n=5), respectively. In contrast, marked differences were observed when the open dwell life times of the three channel types were analyzed (Fig. 5 ). The frequency distributions of the open durations for hKv1.2–1.1wt, hKv1.2–1.1V408A, and hKv1.1V408A channels were well fitted with a single exponential probability density function and the time constants resulted to be 14.3 ± 0.8 ms, 8.5 ± 0.6 ms and 4.8 ± 0.6 ms (n=3), respectively (Fig. 5) . These results demonstrate that V408A mutation reduces the mean open duration of homomeric channels ~threefold, probably destabilizing the conformational changes this region of the channel protein undergoes after a depolarization (33) . In addition, the data demonstrate that this alteration is proportionally transferred to the heteromeric complex and that the Val 408 residue plays a pivotal role in the stability of the open state of the channel.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 4. Representative inside-out patch recordings from oocytes expressing the indicated channels. Openings were evoked by depolarizing voltage pulses of 200 ms duration and delivered every 5 s from a holding potential of -80 mV. The recordings showed were leak subtracted by using averaged sweeps with no opening.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 5. V408A mutations reduce the open duration of homomeric and heteromeric channels. Open duration histograms computed at +20 mV from inside-out single-channel patches. A) hKv1.2–1.1wt ({tau}= 12.4 ms, total events: 9599); B) hKv1.2–1.1V408A ({tau}= 7.5 ms, total events: 4921); C) hKv1.1V408A channels ({tau}= 5.4 ms, total events: 7014). The smooth line represents the fit of each data set with a single exponential probability density function; time constants are corrected for missed brief events.

EA-1 mutations affect cell resting potential
Previous studies have shown that E325D mutations markedly reduce channel expression, possibly because most of the protein remains in the endoplasmic reticulum where it is subsequently degraded (12 , 13) . To determine the effects of such mutation on the expression pattern of heteromeric channels, we coinjected in Xenopus oocytes 2.5 ng of hKv1.2 mRNA with 2.5 ng of hKv1.1wt or hKv1.1E325D mRNA. The relevant average whole-cell currents were plotted in comparison with the currents obtained from oocytes injected with 5 ng of hKv1.1wt, hKv1.1E325D, or hKv1.2 mRNAs alone (Fig. 6 As expected, E325D mutation reduced the expression level of homomeric channels by severalfold and, the currents obtained from oocytes coinjected with equal amounts of hKv1.2 and hKv1.1E325D mRNA were ~0.5 of the control currents.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 6. Coexpression of hKv1.2 with hKv1.1 wild-type and hKv1.1E325D subunits and effects on cell resting potentials. Mean current amplitudes at +40 mV (A) and resting membrane potentials (B) recorded from oocytes injected with the indicated mRNAs (mean±SE of 10–18 cells). This experiment was performed three times and gave similar results. C) Effects of the superfusion of TEA ions on the resting potential of uninjected cells (filled circles; 96 mM) or expressing hKv1.1wt channels (triangles: 3 mM; open circles: 96 mM). The bar above the records indicate the period when the perfusing solution was changed to one that contained tetraethyl-ammonium chloride, which was replaced for NaCl (mean±SE, n=6).

Homomeric hKv1.1E325D channels showed a half-maximal activation voltage V1/2 and a slope factor k of 29.4 ± 1.9 mV and 24.0 ± 1.0 mV, respectively (12 , 13) . These values were ~2.2-fold and ~3.7-fold greater than hKv1.2 homomers (Table 1) . On the other hand, channels resulting from the expression of hKv1.2–1.1E325D concatemer, which are expected to be composed of two subunits of each type, possess voltage-dependent parameters intermediate between hKv1.2 and hKv1.1E325D homomers (Table 1) . Therefore, measurement of the voltage-dependent parameters of currents resulting from the coexpression of equal amounts of hKv1.2 or hKv1.1E325D mRNA gives an estimate of the relative proportion of the channel species that would be mostly formed. The V1/2 and slope factor k determined from these cells were -3.6 ± 0.7 mV and 10.5 ± 0.2 mV (n=8), respectively. These values were slightly more similar to those of hKv1.2 (Table 1) , suggesting that this channel type is relatively more abundant on the plasma membrane.

We observed that the expression of hKv1.1 wild-type channels in Xenopus oocytes shifted the resting membrane potential of the cell ~20 mV to more hyperpolarized potentials compared with uninjected oocytes (Fig. 6B ). A similar effect was observed when hKv1.2 and hKv1.1wt mRNAs were coinjected or by the expression of the hKv1.2–1.1wt concatemer. In contrast, the expression of hKv1.1E325D channels was no longer able to significantly modify the resting potential of the cell. Moreover, when equal amounts of hKv1.2 and hKv1.1E325D mRNAs were coinjected, the membrane potential was shifted by only ~7 mV (Fig. 6B ).

To determine the effects of hKv1.1E325D or hKv1.2 expression on the ability of the hKv1.2–1.1wt concatemer to shift the cell resting potential, equal amounts of both mRNAs were coinjected. The coexpression of the hKv1.2–1.1wt concatemer with hKv1.1E325D or hKv1.2 shifted the resting potential of the cell ~7 mV and ~15 mV to more hyperpolarized potentials, respectively.

To further confirm the role of hKv1.1wt and hKv1.1E325D channels to setting the cell resting potential, different concentrations of TEA were superfused on oocytes expressing these channels and the membrane potentials were recorded. By reversibly blocking hKv1.1wt channels in a concentration-dependent fashion, TEA ions shifted the cell resting potentials toward values that were normally recorded in uninjected oocytes (Fig. 6C ). The superfusion of cells expressing hKv1.1E325D channels with a solution containing a maximal concentration of TEA (96 mM) had no effect on their resting potential (not shown).

Taken together, these results demonstrate that both homomeric and heteromeric channels comprised of hKv1.2 and hKv1.1 subunits may contribute significantly to setting the cell resting potential, and that episodic ataxia mutations markedly impair this property by reducing channel expression and shifting the voltage range of channel activation to more depolarized potentials.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
We have sought to demonstrate in a heterologous expression system whether human Kv1.2 and Kv1.1 subunits coassemble to generate channels with novel gating characteristics and whether these are modified by mutations found in the KCNA1 gene of EA-1-affected patients. Our results demonstrate that heteromeric channels composed of two hKv1.2 and two hKv1.1 subunits possess distinct voltage dependence, kinetics of activation and deactivation, and sensitivity to the TEA ion blockade. However, when EA-1 mutations such as E325D and V408A were introduced into this heteromeric channel, its gating mechanisms were significantly altered. Specifically, E325D mutations markedly shifted the voltage dependence of activation of hKv1.2–1.1E325D channels to more positive potentials. In addition, both V408A and E325D mutations dramatically increased the rate of activation, deactivation, and C-type inactivation of the heteromeric complex.

The single-channel conductance of all these channel types was not significantly different. However, a more detailed analysis of V408A channels revealed new pathogenetic mechanisms caused by this mutation, namely, a marked reduction of the open duration of both homomeric and heteromeric channels. All these observations suggest that the highly conserved residue Val 408 resides in a pivotal region of the protein that controls the correct opening and inactivation of the channel. This is consistent with the postulated presence of an intracellular gate located in this region, whose function may be affected even by minor amino acid changes such as the V408A mutation (33) . Also, the increased rates of deactivation and recovery from C-type inactivation caused by E325D and V408A mutations, in addition to the single-channel results, suggest that these residues influence the stability of the open and inactivated state of both homomeric and heteromeric channels.

Evidence strongly suggests that Kv1.1 and Kv1.2 subunits form heteromeric channels in hippocampal granule cells and CA3 pyramidal cell terminals, in myelinated and unmyelinated axons, and in cerebellar basket cell terminals (21 , 22 23 24 25) . This study demonstrated that heteromeric channels composed of hKv1.1 and hKv1.2 subunits possess peculiar biophysical properties that may confer distinctive electrophysiological features to the neurons expressing this channel type. E325D mutations nearly nullify the expression of the channel, suggesting that the availability of hKv1.1 subunits for heteropolymerization with the hKv1.2 in specific subsets of neurons may be reduced. This effect by itself may provoke the expression of the homomeric hKv1.2 channel type and modify neuronal excitability accordingly. On the other hand, when wild-type and mutant subunits are coexpressed (13) , the voltage-dependent parameters of the currents obtained are similar to the relevant concatamers (12) , revealing that the above mentioned phenomenon does not predominate.

The ability of these channels to set the cell resting potential suggests that in axons where they are the main class of channels expressed (34) , they may play a major role in determining such potential. EA-1 mutations markedly impair this important property of both homomeric and heteromeric channels, suggesting that in affected patients axons and terminals may be hyperexcitable because their resting potentials are shifted to more depolarized values.

The blockade of hKv1.2 and hKv1.1 channels by {alpha}-DTX causes a dramatic increase of GABA release from the basket cell terminals (27) . EA-1 mutations, by affecting the level of expression and several biophysical channel properties, markedly reduce both homomeric hKv1.1 and heteromeric hKv1.2–1.1 delayed-rectifier channel function, which may be qualitatively comparable to the {alpha}-DTX blocking effects. In addition, heteromeric channels bearing EA-1 mutations enter the C-type inactivation state with a faster rate constant, suggesting that during high frequency spiking, the accumulation of this inactivation process may further reduce the number of active channels. Therefore, it is conceivable that in EA-1-affected patients, prolongation of the action potential duration and the increased excitability of the presynaptic basket cell membranes may markedly increase the release of {gamma}-aminobutyric acid from such terminals onto Purkinje cells (Fig. 7 ). Moreover, a basket cell makes contacts with a number of Purkinje cells. Consequently, a single EA affected basket cell may at the same time alter the output of several Purkinje cells. As a result, the output of the entire cerebellum to the rest of the brain may be markedly altered, leading to the attacks of generalized spastic muscle contractions characteristic of EA-1 syndrome.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 7. Proposed effects of EA-1 mutations on basket cells and Purkinje cells inhibitory outputs. The diagram shows a basket cell that has synapses on the initial segment and soma of a number of Purkinje cells from the cerebellar cortex of a normal individual (A) compared to an EA-1-affected patient (B). The reduced delayed rectifier function of both EA-1 homomeric hKv1.1 and heteromeric channels comprised of hKv1.1 and hKv1.2 subunits, which are expressed at the presynaptic level of basket cells, may prolong their action potential duration, increase the membrane excitability and Ca2+ ion influx. The release of larger amounts of {gamma}-aminobutyric acid may result, reducing the inhibitory outputs of the relevant Purkinje cells.

The heteropolymerization of mammalian voltage-dependent potassium channel subunits appears to be confined among members of the same subfamily (35) . This study suggests that whenever EA-1 subunits form an heteromeric complex with any of the other subunits from the Kv1 subfamily, they alter the delayed rectifier function of the resulting channel. Therefore, such phenomena may markedly broaden the electrophysiological alterations caused by the EA-1 mutations in the central and peripheral nervous systems of affected patients.

The reported effects of EA-1 mutations on both homomeric and heteromeric channels suggest that the action potential duration of central and peripheral myelinated axons are broadened in EA-1-affected patients. These conclusions are consistent with the prolonged compound action potential and altered refractory period observed in myelinated axons of mice lacking the entire Kv1.1 gene (36) . Even though the Kv1.1 null mouse is behaviorally distinct from the EA-1 phenotype, the stress-induced tremors in these animals are reminiscent of attacks of episodic ataxia (37) .

In conclusion, these findings show that human Kv1.2 and Kv1.1 potassium channel subunits heteropolymerize to form a unique channel and uncover novel pathogenetic mechanisms of episodic ataxia whereby mutations in a single gene disrupt the functions of other closely related proteins.


   ACKNOWLEDGMENTS
 
We are grateful to John Adelman, James Maylie, Stephen Tucker, and Augusto Di Castelnuovo for fruitful discussions and insightful suggestions and to Mark A. Tanouye and Patricia Zerr for the generous gifts of the human Kv1.2 clone and hKv1.1Y379V mutant, respectively. We thank the Animal Care Unit, the Art Department, Alfonso Abbonizio, Giuseppe Benedetti, Riccardo Malandra, Pietro Pierorazio, Antonio Sese, and Lucia Simigliani for invaluable technical assistance and enthusiastic interaction. The financial support of Telethon-Italy (Grants no. 817 and 1083) and the Italian National Research Council (grant 1998) is gratefully acknowledged. M.C.D'A. is a fellow of the Alfredo Leonardi Fund and G. L. Pfeiffer Foundation.


   FOOTNOTES
 
2 Abbreviations: EA-1, episodic ataxia type-1; GABA, {gamma}-aminobutyric acid; TEA, tetraethyl-ammonium.

Received for publication January 4, 1999. Revision received March 24, 1999.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Van Dyke, D. H., Griggs, R. C., Murphy, M. J., Goldstein, M. N. (1975) Hereditary myokymia and periodic ataxia. J. Neurol. Sci. 25,109-118[Medline]
  2. Brunt, E. R. P., van Weerden, T. W. (1990) Familial paroxysmal kinesigenic ataxia and continuous myokymia. Brain 113,1361-1382[Abstract/Free Full Text]
  3. Gancher, S. T., Nutt, J. G. (1986) Autosomal dominant episodic ataxia: a heterogeneous syndrome. Movement Disorders 1,239-253
  4. Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., van Eijk, R., Oefner, P. J., Hoffman, S. M. G., Lamerdin, J. E., Mohrenweiser, H. W., Bulman, D. E., Ferrari, M., Haan, J., Lindhout, D., van Ommen, G. J., Hofker, M. H., Ferrari, M. D., Frants, R. R. (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87,543-552[Medline]
  5. Scheffer, H., Brunt, E. R., Mol, G. J., van der Vlies, P., Stulp, R. P., Verlind, E., Mantel, G., Averyanov, Y. N., Hofstra, R. M., Buys, C. H. (1998) Three novel KCNA1 mutations in episodic ataxia type I families. Hum. Genet. 102,464-466[Medline]
  6. Browne, D. L., Gancher, S. T., Mutt, J. G., Brunt, E. R. P., Smith, E. A., Kramer, P., Litt, M. (1994) Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 8,136-140[Medline]
  7. Browne, D. L., Brunt, E. R. P., Griggs, R. C., Nutt, J. G., Gancher, S. T., Smith, E. A., Litt, M. (1995) Identification of two new KCNA1 mutations in episodic ataxia/myokymia families. Hum. Mol. Genet. 4,1671-1672[Free Full Text]
  8. Comu, S., Giuliani, M., Narayanan, V. (1996) Episodic ataxia and myokymia syndrome: a new mutation of potassium channel gene Kv1.1. Ann. Neurol. 40,684-687[Medline]
  9. Litt, M., Kramer, P., Browne, D., Gancher, S., Brunt, E. R. P., Root, D., Phromchotikul, T., Dubay, C. J., Nutt, J. (1994) A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am. J. Hum. Genet. 55,702-709[Medline]
  10. Sanguinetti, M. C., Spector, P. S. (1997) Potassium channelopathies. Neuropharmacology 36,755-762[Medline]
  11. Gordon, N. (1998) Episodic ataxia and channelopathies. Brain Dev 20,9-13[Medline]
  12. D'Adamo, M. C., Liu, Z., Adelman, J. P., Maylie, J., Pessia, M. (1998) Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel. EMBO J 17,1200-1207[Medline]
  13. Zerr, P., Adelman, J. P., Maylie, J. (1998) Episodic ataxia mutations in Kv1.1 alter potassium channel function by dominant negative effects or haploinsufficiency. J. Neurosci. 18,2842-2848[Abstract/Free Full Text]
  14. Zerr, P., Adelman, J. P., Maylie, J. (1998) Characterization of three episodic ataxia mutations in the human Kv1.1 potassium channel. FEBS Lett 431,461-464[Medline]
  15. Adelman, J. P., Bond, C. T., Pessia, M., Maylie, J. (1995) Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15,1449-1454[Medline]
  16. Ruppersberg, J. P., Schroter, K. H., Sakmann, B., Stocker, M., Sewing, S., Pongs, O. (1990) Heteromultimeric channels formed by rat brain potassium-channel proteins. Nature (London) 345,535-537[Medline]
  17. Isacoff, E. Y., Jan, N. Y., Jan, L. Y. (1990) Evidence for the formation of heteromultimeric potassium channels in Xenopus oocytes. Nature (London) 345,530-534[Medline]
  18. Christie, M. J., North, R. A., Osborne, P. B., Douglass, J., Adelman, J. P. (1990) Heteropolymeric potassium channels expressed in Xenopus oocytes from cloned subunits. Neuron 2,405-411
  19. Po, S., Roberds, S., Snyders, D. J., Tamkun, M. M., Bennett, P. B. (1993) Heteromultimeric assembly of human potassium channels. Molecular basis of a transient outward current?. Circ. Res. 72,1326-1336[Abstract/Free Full Text]
  20. Beckh, S., Pongs, O. (1990) Members of the RCK potassium channel family are differentially expressed in the rat nervous system. EMBO J 9,777-782[Medline]
  21. McNamara, N. M., Muniz, Z. M., Wilkin, G. P., Dolly, J. O. (1993) Prominent location of a K+ channel containing the {alpha} subunit Kv1.2 in the basket cell nerve terminals of rat cerebellum. Neuroscience 57,1039-1045[Medline]
  22. Wang, H., Kunkel, D. D., Martin, T. M., Schwartzkroin, P. A., Tempel, B. L. (1993) Heteromultimeric K+ channels in terminal and juxtaparanodal regions of neurons. Nature (London) 365,75-79[Medline]
  23. Wang, H., Kunkel, D. D., Schwartzkroin, P. A., Tempel, B. L. (1994) Localization of Kv1.1 and Kv1.2, two K+ channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain. J. Neurosci. 14,4588-4599[Abstract]
  24. Hopkins, W. F., Allen, M. L., Houamed, K. M., Tempel, B. L. (1994) Properties of voltage-gated K+ currents expressed in Xenopus oocytes by mKv1.1, mKv1.2 and their heteromultimers as revealed by mutagenesis of the dendrotoxin-binding site in mKv1.1. Pfluegers Arch 428,382-390[Medline]
  25. Laube, G., Roper, J., Pitt, J. C., Sewing, S., Kistner, U., Garner, C. C., Pongs, O., Veh, R. W. (1996) Ultrastructural localization of Shaker-related potassium channel subunits and synapse-associated protein 90 to separate-like junctions in rat cerebellar Pinceaux. Mol. Brain Res. 42,51-61[Medline]
  26. Korn, H., Axelrad, H. (1980) Electrical inhibition of Purkinje cells in the cerebellum of the rat. Proc. Natl. Acad. Sci. USA 77,6244-6247[Abstract/Free Full Text]
  27. Southan, A. P., Robertson, B. (1998) Patch-clamp recordings form cerebellar basket cell bodies and their presynaptic terminals reveal an asymmetric distribution of voltage-gated potassium channels. J. Neurosci. 18,948-955[Abstract/Free Full Text]
  28. Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., Pease, L. R. (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77,61-68[Medline]
  29. Hoshi, T., Zagotta, W. N., Aldrich, R. W. (1994) Shaker potassium channel gating I: transitions near the open state. J. Gen. Physiol. 103,249-278[Abstract/Free Full Text]
  30. Heginbotham, L., MacKinnon, R. (1992) The aromatic binding site for tetraethylammonium ion on potassium channels. Neuron 8,483-491[Medline]
  31. Choi, K. L., Mossman, C., Aube, J., Yellen, G. (1993) The internal quaternary ammonium receptor site of Shaker potassium channels. Neuron 10,533-541[Medline]
  32. Lopez, G. A., Jan, J. N., Jan, L. Y. (1994) Evidence that the S6 segment of the voltage-gated K+ channel comprises part of the pore. Nature (London) 367,179-182[Medline]
  33. Liu, Y., Holmgren, M., Jurman, M. E., Yellen, G. (1997) Gated access to the pore of a voltage-dependent K+ channel. Neuron 19,175-184[Medline]
  34. Hille, B. (1992) Ionic Channels of Excitable Membranes Second Ed Sinauer Sunderland, Massachusetts.
  35. Covarrubias, M., Wei, A. A., Salkoff, L. (1991) Shaker, Shal, Shab, and Shaw express independent K+ current systems. Neuron 7,763-773[Medline]
  36. Smart, S. L., Lopantsev, V., Zhang, C. L., Robbins, C. A., Wang, H., Chiu, S. Y., Schwartzkroin, P. A., Messing, A., Tempel, B. L. (1998) Deletion of the Kv1.1 potassium channel causes epilepsy in mice. Neuron 20,809-819[Medline]
  37. Zhou, L., Zhang, C. L., Messing, A., Chiu, S. Y. (1998) Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. J. Neurosci. 18,7200-7215[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
P. Imbrici, M. C. D'Adamo, A. Cusimano, and M. Pessia
Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C778 - C787.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
R. J. G. Cardnell, D. E. Dalle Nogare, B. Ganetzky, and M. Stern
In Vivo Analysis of a Gain-of-Function Mutation in the Drosophila eag-Encoded K+ Channel
Genetics, April 1, 2006; 172(4): 2351 - 2358.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan
Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Pharmacol. Rev., December 1, 2000; 52(4): 557 - 594.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
W. Liu and S. Linn
Proteolysis of the human DNA polymerase {varepsilon} catalytic subunit by caspase-3 and calpain specifically during apoptosis
Nucleic Acids Res., November 1, 2000; 28(21): 4180 - 4188.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. N. Manganas, S. Akhtar, D. E. Antonucci, C. R. Campomanes, J. O. Dolly, and J. S. Trimmer
Episodic Ataxia Type-1 Mutations in the Kv1.1 Potassium Channel Display Distinct Folding and Intracellular Trafficking Properties
J. Biol. Chem., December 21, 2001; 276(52): 49427 - 49434.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by D'Adamo, M. C.
Right arrow Articles by Pessia, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by D'Adamo, M. C.
Right arrow Articles by Pessia, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS